Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

CRISPR For Genome Editing

CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease.